Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
iShares Genomics Immunology and Healthcare ETF (IDNA)
USD32.95
-0.60 (-1.79%)
AMEX USD US Equity
NAV
USD 33.46
-1.52% vs NAV
as of 2026-07-13
AUM
USD 195.75M
TER
0.47%
Yield (TTM)
0.85%
Distribution
Distributing · Semi-Annual
52-week range
20.93 – 34.91
Holdings
61
Issuer
IShares
About this ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
ISIN
US46435U1925
Issuer
IShares
Domicile
US
Inception
2019-06-11
Asset class
Equity
Price
Top 10 holdings
| MODERNA INC MRNA | 5.05% |
| BAYER AG BAYN.DE | 4.80% |
| TWIST BIOSCIENCE CORP TWST | 4.59% |
| REVOLUTION MEDICINES INC RVMD | 4.39% |
| GENMAB GMAB.CO | 4.06% |
| INCYTE CORP INCY | 4.00% |
| VERTEX PHARMACEUTICALS INC VRTX | 3.81% |
| TAKEDA PHARMACEUTICAL LTD 4502.T | 3.78% |
| EXELIXIS INC EXEL | 3.76% |
| REGENERON PHARMACEUTICALS INC REGN | 3.67% |
Sector mix
Price chart
USD32.95
-0.60 (-1.79%)
Loading historical data…
Returns
| 1 month | +15.01% |
| 3 months | +12.38% |
| 6 months | +19.73% |
| Year to date | +25.81% |
| 1 year | +52.26% |
| 3 years (ann.) | +13.08% |
| 5 years (ann.) | -8.72% |
| 10 years (ann.) | — |
Risk profile
| Volatility (1y, ann.) | 25.35% |
| Sharpe (1y) | 1.79 |
| Sharpe (3y) | 0.61 |
| Sortino (1y) | 3.35 |
| Max drawdown (1y) | -10.66% |
| Max drawdown (5y) | -68.69% |
| Max drawdown (full) | -68.69% |
| Beta vs S&P 500 (1y) | 1.05 |
| Correlation vs S&P 500 (1y) | 0.52 |
Technical outlook as of 2026-07-13
Day Score (bias 0-100, not a probability)
53
P(gain) 22 sessions — probability
52%
VaR 95% (daily)
-2.87%
CVaR 95% (daily)
-4.05%
GARCH vol forecast (22d)
1.74%
Market regime (Markov)
Lateral
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Top-10 concentration
41.9%
Effective holdings
31
Disclosed positions
61
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Loading map…
Cost vs. peers
IDNA
0.47%
Equity median
0.39%
Cheapest in class BKLC
0.00%
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Distributing share class Income is paid out to shareholders.
| Ex-date | Payment | Amount |
|---|---|---|
| 2026-06-15 | 2026-06-18 | USD 0.1254 |
| 2025-12-16 | 2025-12-19 | USD 0.1555 |
| 2025-06-16 | 2025-06-20 | USD 0.1529 |
| 2024-12-17 | 2024-12-20 | USD 0.1111 |
| 2024-06-11 | 2024-06-17 | USD 0.1114 |
| 2023-12-20 | 2023-12-27 | USD 0.1693 |
| 2023-06-07 | 2023-06-13 | USD 0.0708 |
| 2022-06-09 | 2022-06-15 | USD 0.1359 |
| 2021-12-13 | 2021-12-17 | USD 0.2564 |
| 2021-06-10 | 2021-06-16 | USD 0.0521 |
| 2020-12-14 | 2020-12-18 | USD 0.0362 |
| 2020-06-15 | 2020-06-19 | USD 0.0837 |
| 2019-12-16 | 2019-12-20 | USD 0.2402 |
ESG profile
Derived from holdings
covers 63.9% of the portfolio by weight
(32 scored constituents)
Environmental
59.2
class avg 63.0
Social
62.5
class avg 62.3
Governance
62.4
class avg 64.9
Total ESG
61.4
class avg 63.4
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| iShares Core MSCI EAFE ETF IEFA | 0.07% | 187.22B | 2.5% |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 1.9% |
| Vanguard Value ETF VTV | 0.03% | 245.00B | 1.4% |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 1.4% |
| iShares Core MSCI World UCITS ETF IWDA.L | 0.20% | 143.34B | 1.3% |
